


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.59%
-2.58%
+8.85%
-1.56%
+8.59%
PEN
Penumbra
$359.03
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
PEN Price Performance
$316.97 (+13.27%)
$226.19 (+58.73%)
$276.4 (+29.90%)
$271.14 (+32.41%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
PEN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PEN Street Sentiment is extremely bullish and have positive views on the near-term outlook
PEN has Low risk level

PEN
Penumbra
359.03
-0.10%
EXFY
Expensify Inc.
1.46
-2.67%
AVA
Avista Corporation C
40.36
-1.46%
VERU
Veru
2.60
-2.99%
TMO
Thermo Fisher
608.02
-2.55%
What is PEN current stock price?
What are PEN stock strengths?
What is PEN Risk Level?
What is PEN market cap and volume?
What is PEN current Stock IQ?
Should I buy PEN stock right now?
Is PEN a Strong Buy right now?
What does a 'Strong Buy' rating mean for PEN?
What does a 'Strong Sell' rating mean for PEN?
What factors influence PEN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.59%
-2.58%
+8.85%
-1.56%
+8.59%
PEN
Penumbra
Current Price
$359.03
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Recently Viewed
PEN
Penumbra
359.03
-0.10%
EXFY
Expensify Inc.
1.46
-2.67%
AVA
Avista Corporation C
40.36
-1.46%
VERU
Veru
2.60
-2.99%
TMO
Thermo Fisher
608.02
-2.55%

PEN Price Performance
$316.97 (+13.27%)
$226.19 (+58.73%)
$276.4 (+29.90%)
$271.14 (+32.41%)
PEN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
PEN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PEN Street Sentiment is extremely bullish and have positive views on the near-term outlook
PEN has Low risk level

Overall Wall Street Rating
STRONG BUY
Dec 19, 2025
Reiterate
Buy
Truist Securities
Dec 19, 2025
Upgrade
Overweight
JP Morgan
Dec 18, 2025
Reiterate
Buy
Needham
Nov 07, 2025
Reiterate
Neutral
JP Morgan
Oct 27, 2025
Reiterate
Buy
Needham
Oct 27, 2025
Reiterate
Buy
BTIG
PEN Stock IQ
PEN Latest Analysis
Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientifics (BSX) Mew Market Dominance. Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16 Oppenheimer lowered its price target on Boston Scientific to $100 from $125 with an Outperform rating. Oppenheimer is cautious on the financial optics of Boston Scientifics $14.5 billion acquisition of Penumbra. Although the deal creates a [….]
Fri Jan 23, 2026
Penumbra (PEN) Climbs to All-Time High on $14.5-Billion Merger. We recently published 10 Stock With Eye-Popping Gains. 5 Are on Fresh Highs. Penumbra Inc. (NYSE:PEN) was one of the top performers on Thursday. Penumbra soared to a new all-time high on Thursday as investors snapped up shares following announcements that it is set to be acquired by Boston Scientific Corporation for $14.5 billion. At [….]
Fri Jan 16, 2026
Penumbra (PEN) Moves 11.8% Higher: Will This Strength Last?. Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Fri Jan 16, 2026
Boston Scientific To Acquire Penumbra. Stock Soars . (RTTNews) - Boston Scientific Corp. (BSX) announced today that it has entered into a definitive agreement to acquire Penumbra Inc. (PEN) for $374 per share reflecting an enterprise value of roughly $14.5 billion.
Thu Jan 15, 2026
Penumbra Q4 Prel. Revenue Rises . (RTTNews) - Penumbra Inc. (PEN) a medical devices manufacturer Thursday reported that its preliminary fourth quarter revenue and full year revenue have increased around 21.4 percent to 22 percent and around 17.3 percent to 17.5 percent respectively.
Thu Jan 15, 2026
Penumbra gains amid takeover speculation.
Wed Jan 14, 2026
Penumbra Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Tue Jan 13, 2026
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.